Despite revenue challenges, Emergent BioSolutions Inc (EBS) raises guidance and expands NARCAN distribution to meet growing ...

On Wednesday, Emergent Biosolutions Inc (EBS) stock saw a decline, ending the day at $8.93 which represents a decrease of $-0.29 or -3.15% from the prior close of $9.22. The stock opened at $9.16 and ...

Emergent BioSolutions shows signs of turnaround with restructuring and new contracts in biodefense, but risks remain. Check ...

Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to ...

Emergent BioSolutions stock is trading higher after the company announced the closing of a $100 million asset-backed ...

Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to Rescue public awareness campaign to expand awareness, p ...

马里兰州盖瑟斯堡 - 生物制药公司Emergent BioSolutions Inc. (NYSE: EBS)周一宣布建立了一项新的资产抵押循环贷款额度(ABL)。该协议涉及贷款方和Wells Fargo Bank作为管理代理人，为Emergent提供高达1亿美元的循环贷款。这项金融安排将于2029年9月30日到期，但根据公司其他重大债务义务的某些条件，可能会提前到期。 这项新的信贷额度旨在作为E ...

Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $9.35 which represents a slight increase of $0.41 or 4.59% from the prior close of $8.94. The stock opened at $9.04 and ...

Emergent BioSolutions Inc.宣布向其执行副总裁、首席财务官兼财务主管Richard S. Lindahl授予特别一次性股权奖励。 董事会薪酬委员会于周三批准授予15,000个限制性股票单位，这些单位将于2025年10月15日归属，前提是Lindahl届时仍在公司任职。

Emergent BioSolutions secures $400M in orders for smallpox and mpox products, receives FDA approval for ACAM2000's expanded ...